Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic

Visuddho; Nabil Alfin Juhri; Ludy Diana Wiradhika; Reny I’tishom

doi:10.30574/wjarr.2022.13.1.0020

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 || CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic

Visuddho ¹^,, Nabil Alfin Juhri ¹, Ludy Diana Wiradhika ¹ and Reny I’tishom ^{2, }

¹Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

² Department of Biomedical Sciences, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Review Article

World Journal of Advanced Research and Reviews, 2022, 13(01), 468-472

Article DOI: 10.30574/wjarr.2022.13.1.0020

DOI url: https://doi.org/10.30574/wjarr.2022.13.1.0020

Publication history

Received on 06 December 2021; revised on 10 January 2022; accepted on 12 January 2022

Abstract

The use of corticosteroids during the (Coronavirus Disease 2019) COVID-19 has become a new concern. Corticosteroids are the main therapy in asthmatic patients with anti-inflammatory and immunosuppressant effects. Patients with the need for long-term use of corticosteroids, such as asthma patients, are aware of the risk from infection obtained by the side effect of long-term corticosteroid use. A Recent study has innovated a new drug delivery agent, called Microsphere that can specify the targeted therapy. This new therapy may potentially increase the treatment efficacy with the lesser side effects. Here we review a study that uses the Microsphere for delivering corticosteroids. Additional studies are warranted to support the use of Microspheres as novel drug delivery for asthma patients during the COVID-19 pandemic.

Keywords

Asthma; Corticosteroids; COVID-19; Microsphere; Therapy

Download Article PDF

https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-0020.pdf

Preview Article PDF

How to cite this article

Visuddho, Nabil Alfin Juhri, Ludy Diana Wiradhika and Reny I’tishom. Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic. World Journal of Advanced Research and Reviews, 2022, 13(1), 468-472. Article DOI: https://doi.org/10.30574/wjarr.2022.13.1.0020

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Developed & Designed by VS Infosolution

Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic

Visuddho ¹^,, Nabil Alfin Juhri ¹, Ludy Diana Wiradhika ¹ and Reny I’tishom ^{2, }

Preview Article PDF

Get Certificates

Issue details

Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic

Visuddho 1,*, Nabil Alfin Juhri 1, Ludy Diana Wiradhika 1 and Reny I’tishom 2, *

Preview Article PDF

Get Certificates

Issue details

Visuddho ¹^,, Nabil Alfin Juhri ¹, Ludy Diana Wiradhika ¹ and Reny I’tishom ^{2, }